2023-510452-23-00CompletedPhase 1
An Early Phase Study to Investigate the Safety and Efficacy of HS135 in Adult Patients With Pulmonary Arterial Hypertension (PAH)
Source: EU CTIS (euclinicaltrials.eu) · Last updated 2 Oct 2024
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- First submitted
- 29 Feb 2024
- Start date
- 29 Oct 2024
- Lead sponsor
- 35Pharma Inc.
- Diseases
- Pulmonary arterial hypertension
- EU CT number
- 2023-510452-23-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 16
- 5 sites in 3 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (5)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR | Dresden | Germany | Completed |
| Universitätsmedizin Greifswald | Greifswald | Germany | Completed |
| Medizinische Hochschule Hannover | Hanover | Germany | Completed |
| Semmelweis University | Budapest VIII | Hungary | Completed |
| Krakowski Szpital Specjalistyczny Im. Sw. Jana Pawla II | Cracow | Poland | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.